Explore our oncology portfolio by product, generic name, therapeutic category, dosage form, strength and availability.
TKIs & small-molecule oncology
Hormone-based cancer therapies
Cytotoxic injectables & therapies
Supportive-care medicines
Biologics & monoclonal antibodies
PARP inhibitors & emerging agents
| Product / Generic | Strength | Dosage Form | Category |
|---|---|---|---|
| Sunitinib Malate | 12.5 mg / 50 mg | Capsules | Targeted Therapy |
| Dasatinib | 50 mg | Tablets | Targeted Therapy |
| Bicalutamide | 50 mg | Tablets | Hormonal Oncology |
| Abiraterone Acetate | 500 mg | Tablets | Hormonal Oncology |
| L-Asparaginase | 10,000 IU | Injection (Lyophilized) | Chemotherapy |
| Bendamustine Hydrochloride | 100 mg/vial | Injection | Chemotherapy |
| Leucovorin Calcium Calcium Folinate | 50 mg/5ml | Injection | Supportive Care |
| Eltrombopag | 50 mg | Tablets | Supportive Care |
| Rucaparib | 300 mg | Tablets | PARP Inhibitor |
| Trastuzumab | 150 mg | Injection (Lyophilized) | Biologic |
| Daratumumab | 100 mg/vial | Injection (Concentrate) | Biologic |
* Sample products shown are representative only. Please confirm the final product list, availability and regulatory status against the master catalogue.
Each product page is structured to provide essential information for distributors, hospitals and healthcare procurement partners.
Product name and composition details.
Strength, dosage form and presentation.
Relevant oncology therapeutic classification.
Available packaging and presentation details.
Applicable manufacturing and quality standards.
Regulatory documentation available on request.
Market and country availability information.
Contact our team for product details, availability, documentation and international supply enquiries.